Skip to content

Globe Life

US · GL #1263 by market cap Listed 1970
163.41 -2.87 -1.73%
Live - 5344 symbols - heartbeat 28s ago · 2026-10-07 19:54
After-hours 163.41 0.00%
Market cap
12.56B
P/B
2.04
EPS
14.07
Reader sentiment Are you bullish or bearish on GL?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Fair Value how this is computed

Near fair value
136.01 fair value ≈ 171.98 207.94
  • Implied fair-value range of 136.01-207.94, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is -5.0% below the average-multiple fair value of 171.98.

Valuation each multiple against its own 5-year range

P/B ratio 2.06 In line with history 59th percentile
5-year average 1.97 · #19 of 22 in Insurance - Life
P/E ratio 10.97 In line with history 40th percentile
5-year average 12.22 · forward 9.85 · #9 of 18 in Insurance - Life
P/S ratio 2.05 Expensive vs history 76th percentile
5-year average 1.91 · forward 1.91 · #19 of 22 in Insurance - Life

Vs. peers Insurance - Life

Company Market cap P/E (TTM) P/B Div yield
Globe Life (GL) 12.56B 10.87 2.04 0.73%
Manulife Financial (MFC) 68.93B 16.10 2.11 3.13%
MetLife (MET) 60.87B 18.35 2.22 2.40%
Aflac Inc (AFL) 56.52B 12.16 1.86 2.11%
Prudential Financial (PRU) 38.76B 10.19 1.23 4.89%
Prudential (PUK) 29.39B 8.28 1.48 2.26%

Other StockVane-tracked companies in the same industry.

Morningstar

★★☆☆☆ Fair value153.75 Economic moatNarrow UncertaintyHigh

Trading 5.9% above Morningstar's fair value estimate.

Fair value

Globe Life Inc earns a 2-star quantitative star rating, illustrating our stance that this share class is a somewhat unattractive choice, and investors should look elsewhere for more fruitful opportunities. The stock currently trades at a 8% premium over our quantitative fair value estimate of $153.75 per share; however, this estimate should be taken with a pinch of salt due to its high uncertainty rating. We require the price/fair value ratio to move a certain amount before the star rating can change. This stability-enhancing buffer is in effect for this stock.

The firm's balance sheet undermines our estimated valuation. Excessive leverage heightens financial risk, potentially undermining a firm's value. For example, the firm's EBITDA/interest coverage ratio of 11.7 ranks in the bottom 50% compared with peers globally. This gives us pause, as it can be a warning sign of financial distress if conditions don't improve. We believe this is a sign that shares could be expensive.

Alternatively, the firm's valuation metrics are reassuring. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's enterprise value to market value ratio of 1.3, a core component of valuation, lies in the top 40% compared with peers globally. While highly leveraged firms can be risky, they can also be highly rewarding. This company's high enterprise value relative to its market value suggests that wise investments will yield outsize returns for investors. Despite our unfavorable price/fair value ratio, this characteristic is a positive attribute.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance may signify a bull trap, in light of other detractors from our model.

Economic moat

The company's narrow quantitative moat rating indicates it could outearn its cost of capital and maintain robust margins for 10 years or longer. Its moat is bolstered by its strong financial health, which indicates low near-term bankruptcy risk.

By Quantitative Equity Report

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.